Irbesartan ameliorates chronic mountain sickness in a rat model via the cholesterol metabolism: An iTRAQ -based proteomics analysis
Objective: To study the effects of irbesartan on pulmonary artery lesions in a rat model with chronic mountain sickness (CMS) and identify the biomarkers involved. Methods: In this study, we used a rat model of CMS to evaluate the therapeutic effect of irbesartan by measuring pulmonary artery pressu...
Main Authors: | Yiliyaer Nijiati, Tao Yang, Mutalifu Aimaiti, Dilinuer Maimaitiyiming, Ainiwaer Aikemu |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-09-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332221005849 |
Similar Items
-
iTRAQ-based quantitative proteomic analysis of the improved effects of total flavones of Dracocephalum Moldavica L. in chronic mountain sickness
by: Aihaidan Abudouwayiti, et al.
Published: (2021-09-01) -
Solid lipid nanoparticles of irbesartan: preparation, characterization, optimization and pharmacokinetic studies
by: Deepthi Soma, et al.
Published: (2017-04-01) -
Effect of transient scrotal hyperthermia on human sperm: an iTRAQ-based proteomic analysis
by: Yan-Qing Wu, et al.
Published: (2020-08-01) -
iTRAQ-based proteomic analysis of duck muscle related to lipid oxidation
by: Muhan Zhang, et al.
Published: (2021-04-01) -
IRBESARTAN IN THE CLINICAL PRACTICE
by: V. I. Podzolkov, et al.
Published: (2015-09-01)